ArticleEffect of Glucagon Like Peptide 1| (GLP1) Analogues on Obese Egyptians With and Without Diabetes
ArticleEffect of Glucagon Like Peptide 1| (GLP1) Analogues on Obese Egyptians With and Without Diabetes
ArticleInfluence of liraglutide, dulaglutide versus conventional treatment on fatty liver index and fibrosis-4 score in Egyptian patients with type 2 diabetes mellitus and non-alcoholic
ArticleInfluence of liraglutide, dulaglutide versus conventional treatment on fatty liver index and fibrosis-4 score in Egyptian patients with type 2 diabetes mellitus and non-alcoholic
ArticleA Study on the Effect of Glucagon Like Peptide 1 Agonist on Glycemic State, Renal Functions and Some Hemodynamic Parameters in Diabetic Male Albino Rats
ArticleA Study on the Effect of Glucagon Like Peptide 1 Agonist on Glycemic State, Renal Functions and Some Hemodynamic Parameters in Diabetic Male Albino Rats
ArticleThe Effect of Bariatric Surgery on GLP-1, Insulin Resistance and Metabolic Parameters in Patients with T2DM
ArticleThe Effect of Bariatric Surgery on GLP-1, Insulin Resistance and Metabolic Parameters in Patients with T2DM
ArticleEffect of laparoscopic sleeve gastrectomy on glucose tolerance in morbid obese diabetic patients
ArticleEffect of laparoscopic sleeve gastrectomy on glucose tolerance in morbid obese diabetic patients
ArticleEFFECTS OF METFORMIN PLUS GLICLAZIDE VERSUS METFORMIN PLUS GLIMEPIRIDE ON CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
ArticleEFFECTS OF METFORMIN PLUS GLICLAZIDE VERSUS METFORMIN PLUS GLIMEPIRIDE ON CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
ArticleEffect of Qat on the level of blood glucose and lipids among Yemeni patients with type 2 diabetes
ArticleEffect of Qat on the level of blood glucose and lipids among Yemeni patients with type 2 diabetes
ArticleEffectiveness and safety of insulin glargine plus glimepiride after 6 months of treatment among patients with type 2 diabetes mellitus who failed premixed insulin: An observation
ArticleEffectiveness and safety of insulin glargine plus glimepiride after 6 months of treatment among patients with type 2 diabetes mellitus who failed premixed insulin: An observation